Pharmacy Newsflash

Welcome to our new website

Welcome to Pharmacy Innovations, New York and Pennsylvania's FIRST PCAB Accredited Compounding Pharmacies!

Pharmacy Innovations welcomes our newest store! Pharmacy Innovations-Greenville. The store is located at 604 Grove Road, Greenville, SC.  Our stores are open from 9 a.m. to 5:30 p.m. Monday through Friday. For more information, call 484-1586, or any of the other local numbers. 

Please visit our online store for quality vitamins, supplements, skin care products and personal needs. We offer only the highest quality vitamins and supplements. Click HERE to contact us for information on our many gluten free products.

Chrysaderm skin care products now available for only $59.99 per bottle in our online store! Click HERE for more information on our Chrysaderm!

  Details...


Home arrow Compounding for People arrow AVASTIN NOW AVAILABLE AT PHARMACY INNOVATIONS
AVASTIN NOW AVAILABLE AT PHARMACY INNOVATIONS | Print |  E-mail

Avastin now available from Pharmacy Innovations 

Avastin (Bevacizumab) is an anti-angiogenesis agent that was approved in 2004 to treat colon cancer. It works by causing a decrease in the production of blood vessels that feed tumors. Many opthalmologists are now using Avastin to treat wet macular degeneration (AMD) as it is also is thought to stop fluid from leaking out of the blood vessels into the macula of patients suffering from AMD. Currently, improvement in vision may occur within the first week of therapy.

Below is an excerpt from one of the studies that have been done on Avastin:
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.
California Retina Consultants, Santa Barbara, California 93103, USA.
PMID: 16458968 [PubMed - indexed for MEDLINE]

PURPOSE: To report the short-term safety, biologic effect, and a possible mechanism of action of intravitreal bevacizumab in patients with neovascular age-related macular degeneration (AMD).
CONCLUSIONS: Short-term results suggest that intravitreal bevacizumab (1.25 mg) is well tolerated and associated with improvement in VA, decreased retinal thickness by OCT, and reduction in angiographic leakage in most patients, the majority of whom had previous treatment with photodynamic therapy and/or pegaptanib. Further evaluation of intravitreal bevacizumab for the treatment of choroidal neovascularization is warranted.

Source of information: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16458968

Other links for Avastin information:

www.avastin.com 

www.drugs.com/avastin.html


Pharmacy Innovations has been named a preferred supplier of Avastin by Genetech, the manufacturer of Avastin. Prefilled, sterile syringes of bevacizumab for opthalmic use are available for (refrigerated) delivery.

Genentech also has several other medications available through Pharmacy Innovations.

Please call Pharmacy Innovations for more information on prescribing Avastin.

 
© 2012 PharmacyInnovations.net - Pharmacy Innovations-Custom Medication Compounding for people and pets. High Quality Vitamins, Supplements and Skin Care.
Joomla! is Free Software released under the GNU/GPL License.